Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection

Acta Tropica

Volumn 111, Issue 2, 2009, Pages 181-191

  Pinlaor, Somchai ^a   Prakobwong, Suksanti ^a   Boonmars, Thidarut ^a   Wongkham, Chaisiri ^a   Pinlaor, Porntip ^a,b   Hiraku, Yusuke ^c  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokines; Fibrolysis; Matrix metalloproteinase; Opisthorchis viverrini; Peribiliary fibrosis; Praziquantel; Tissue inhibitor of metalloproteinase

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE 3; GELATINASE A; GELATINASE B; HYDROXYPROLINE; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PRAZIQUANTEL; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA;

DISEASE TREATMENT; DOSE-RESPONSE RELATIONSHIP; DRUG; INFECTIOUS DISEASE; INFECTIVITY; MITOCHONDRION; RNA;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; LIVER FIBROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPISTHORCHIASIS; OPISTHORCHIS VIVERRINI; PROTEIN EXPRESSION; SYRIAN HAMSTER; TREATMENT DURATION; UNINDEXED SEQUENCE;

ANIMALS; COLLAGEN; CRICETINAE; GENE EXPRESSION PROFILING; HYDROXYPROLINE; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASES; OPISTHORCHIASIS; OPISTHORCHIS; PRAZIQUANTEL; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; CRICETINAE; OPISTHORCHIS VIVERRINI;

EID: 67349123960     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.04.011     Document Type: Article

References (31)

1. Alenghat T., Yu J., and Lazar M.A. The N-CoR complex enables chromatin remodeler SNF2H to enhance repression by thyroid hormone receptor. EMBO J. 25 (2006) 3966-3974
2. Arthur M.J. Collagenases and liver fibrosis. J. Hepatol. 22 (1995) 43-48
3. Bhamarapravati N., Thammavit W., and Vajrasthira S. Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. Am. J. Trop. Med. Hyg. 27 (1978) 787-794
4. Burke B. The role of matrix metalloproteinase 7 in innate immunity. Immunobiology 209 (2004) 51-56
5. Chotigeat W., and Ruenwongsa P. Types of collagen in Opisthorchis viverrini infected hamster liver. Mol. Biochem. Parasitol. 18 (1986) 377-387
6. el-Badrawy N.M., Abdel Hadi A.M., Voss B., Metwally A.A., and Ebeid F. Effect of praziquantel on the distribution of interstitial collagen types I and III and basement membrane collagen types IV and V in murine hepatic schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 85 (1991) 752-755
7. Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell. Biol. 74 (1997) 111-122
8. Goodman Z.D. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J. Hepatol. 47 (2007) 598-607
9. Harinasuta T., Riganti M., and Bunnag D. Opisthorchis viverrini infection: pathogenesis and clinical features. Arzneimittelforschung 34 (1984) 1167-1169
10. Haro H., Crawford H.C., Fingleton B., Shinomiya K., Spengler D.M., and Matrisian L.M. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J. Clin. Invest. 105 (2000) 143-150
11. Hemmann S., Graf J., Roderfeld M., and Roeb E. Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J. Hepatol. 46 (2007) 955-975
12. Hsu L.S., Lee H.H., Chen K.M., Chou H.L., and Lai S.C. Matrix metalloproteinase-2 and -9 in the granulomatous fibrosis of rats infected with Angiostrongylus cantonensis. Ann. Trop. Med. Parasitol. 99 (2005) 61-70
13. Huh J.W., Kim D.S., Oh Y.M., Shim T.S., Lim C.M., Lee S.D., Koh Y., Kim W.S., Kim W.D., and Kim K.R. Is metalloproteinase-7 specific for idiopathic pulmonary fibrosis?. Chest 133 (2008) 1101-1106
14. IARC. Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus, Clornorchis sinensis). IARC Monographs on the Evaluation of Carcinogenic Risks to Human vol. 61 (1994), International Agency for Research on Cancer, Lyon pp. 121-175
15. Itatsu K., Zen Y., Yamaguchi J., Ohira S., Ishikawa A., Ikeda H., Sato Y., Harada K., Sasaki M., Sakamoto H., Nagino M., Nimura Y., Ohta T., and Nakanuma Y. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Hum. Pathol. 39 (2008) 710-719
16. Jo Chae K., Rha S.Y., Oh B.K., Koo J.S., Kim Y.J., Choi J., Park C., and Park Y.N. Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma. Am. J. Gastroenterol. 99 (2004) 68-75
17. Jongsuksuntigul P., and Imsomboon T. Opisthorchiasis control in Thailand. Acta Trop. 88 (2003) 229-232
18. Kanzler S., Lohse A.W., Keil A., Henninger J., Dienes H.P., Schirmacher P., Rose-John S., zum Buschenfelde K.H., and Blessing M. TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am. J. Physiol. 276 (1999) G1059-1068
19. Lee S.H., Hong S.T., Kim C.S., Sohn W.M., Chai J.Y., and Lee Y.S. Histopathological changes of the liver after praziquantel treatment in Clonorchis sinensis infected rabbits. Kisaengchunghak Chapchi. 25 (1987) 110-122
20. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K., and Flavell R.A. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 24 (2006) 99-146
21. Lichtinghagen R., Michels D., Haberkorn C.I., Arndt B., Bahr M., Flemming P., Manns M.P., and Boeker K.H. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J. Hepatol. 34 (2001) 239-247
22. Mairiang E., Haswell-Elkins M.R., Mairiang P., Sithithaworn P., and Elkins D.B. Reversal of biliary tract abnormalities associated with Opisthorchis viverrini infection following praziquantel treatment. Trans. R. Soc. Trop. Med. Hyg. 87 (1993) 194-197
23. Miwa S., Miyagawa S., Soeda J., and Kawasaki S. Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer 94 (2002) 428-434
24. Pinlaor S., Hiraku Y., Yongvanit P., Tada-Oikawa S., Ma N., Pinlaor P., Sithithaworn P., Sripa B., Murata M., Oikawa S., and Kawanishi S. iNOS-dependent DNA damage via NF-κB expression in hamsters infected with Opisthorchis viverrini and its suppression by the antihelminthic drug praziquantel. Int. J. Cancer 119 (2006) 1067-1072
25. Pinlaor S., Prakobwong S., Hiraku Y., Kaewsamut B., Dechakhamphu S., Boonmars T., Sithithaworn P., Pinlaor P., Ma N., Yongvanit P., and Kawanishi S. Oxidative and nitrative stress in Opisthorchis viverrini-infected hamsters: an indirect effect after praziquantel treatment. Am. J. Trop. Med. Hyg. 78 (2008) 564-573
26. Pinlaor S., Sripa B., Sithithaworn P., and Yongvanit P. Hepatobiliary changes, antibody response, and alteration of liver enzymes in hamsters re-infected with Opisthorchis viverrini. Exp. Parasitol. 108 (2004) 32-39
27. Singh K.P., Gerard H.C., Hudson A.P., and Boros D.L. Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs. Ann. Trop. Med. Parasitol. 98 (2004) 581-593
28. Sripa B., and Kaewkes S. Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis. Int. J. Parasitol. 30 (2000) 735-740
29. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
30. Wynn T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214 (2008) 199-210
31. Yip D., Ahmad A., Karapetis C.S., Hawkins C.A., and Harper P.G. Matrix metalloproteinase inhibitors: applications in oncology. Invest. New Drugs 17 (1999) 387-399